Noise level goes up on AIDS vaccine
Politics & Policy
ROCKVILLE, Md. - Scientific controversy over the risks and benefits of a live attenuated AIDS vaccine came into public view last week, with top NIH officials accusing AIDS physicians who are pushing for human trials of a vaccine of minimizing the dangers and significantly underestimating the amount of work needed before a Phase I trial can begin.
In return, vaccine proponents accused leading U.S. AIDS researchers of delaying development of what they say is the only type of vaccine that has shown a high degree of efficacy.